Market Report Source

Overview

Datamonitor’s OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

• Contains an executive summary and data on value, volume and segmentation
• Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
• Includes a five-year forecast of the industry

Highlights

• The global OTC pharmaceuticals market grew by 4% in 2007 to reach a value of $84.8 billion.
• In 2012, the global OTC pharmaceuticals market is forecast to have a value of $101.8 billion, an increase of 20.1% since 2007.
• Cough and cold preparations form the most lucrative sector of the global market, with an 18.4% share of the market by value.
• The Asia-Pacific is the leading region in the global market, with a 38.8% share of the total market value.
• Pfizer Inc. is the leading company in the global market, with a 6.3% share of the market by value.
• Pharmacies and drugstores form the most lucrative distribution channel, with a 67.2% share of the global market by value.

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Table of Contents

List of Figures

CHAPTER 1 INTRODUCTION
1.1 What is this report about?
1.2 Who is the target reader?
1.3 How to use this report
1.4 Definitions

CHAPTER 2 Global OTC Pharmaceuticals
2.1 Market Overview
Research Highlights
Market Analysis
2.2 Market Value
2.3 Market Segmentation I
2.4 Market Segmentation II
2.5 Market Share
2.6 Five Forces Analysis
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
2.7 Leading Companies
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
2.8 Distribution
2.9 Market Forecasts
Market Value Forecast

CHAPTER 3 OTC Pharmaceuticals in Asia-Pacific
3.1 Market Overview
Research Highlights
Market Analysis
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Market Share

3.6 FIVE FORCES ANALYSIS
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
3.7 Leading Companies
Nin Jiom
Pfizer Inc
Novartis AG
3.8 Distribution
3.9 Market Forecasts
Market Value Forecast

CHAPTER 4 OTC Pharmaceuticals in Europe
4.1 Market Overview
Research Highlights
Market Analysis
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Market Share
4.6 Five Forces Analysis
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
4.7 Leading Companies
Bayer AG
Pfizer Inc
GlaxoSmithKline Plc
4.8 Distribution
4.9 Market Forecasts
Market Value Forecast
4.10 Macroeconomic Indicators

CHAPTER 5 OTC Pharmaceuticals in Belgium
5.1 Market Overview
Research Highlights
Market Analysis
5.2 Market Value
5.3 Market Segmentation I
5.4 Market Segmentation II
5.5 Market Share

5.6 FIVE FORCES ANALYSIS
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
5.7 Leading Companies
Pfizer Inc
Novartis AG
Omega Pharma NV
5.8 Distribution
5.9 Market Forecasts
Market Value Forecast
5.10 Macroeconomic Indicators

CHAPTER 6 OTC Pharmaceuticals in Canada
6.1 Market Overview
Research Highlights
Market Analysis
6.2 Market Value
6.3 Market Segmentation I
6.4 Market Segmentation II
6.5 Market Share

6.6 FIVE FORCES ANALYSIS
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
6.7 Leading Companies
Pfizer Inc
GlaxoSmithKline Plc
Jamieson Laboratories
6.8 Distribution
6.9 Market Forecasts
Market Value Forecast
6.10 Macroeconomic Indicators

CHAPTER 7 OTC Pharmaceuticals in China
7.1 Market Overview
Research Highlights
Market Analysis
7.2 Market Value
7.3 Market Segmentation I
7.4 Market Segmentation II
7.5 Market Share

7.6 FIVE FORCES ANALYSIS
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
7.7 Leading Companies
Johnson & Johnson
7.8 Distribution
7.9 Market Forecasts
Market Value Forecast
7.10 Macroeconomic Indicators

CHAPTER 8 OTC Pharmaceuticals in France
8.1 Market Overview
Research Highlights
Market Analysis
8.2 Market Value
8.3 Market Segmentation I
8.4 Market Segmentation II
8.5 Market Share
8.6 Five Forces Analysis
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
8.7 Leading Companies
Procter & Gamble Company, The
Sanofi-Aventis
Pfizer Inc
8.8 Distribution
8.9 Market Forecasts
Market Value Forecast
8.10 Macroeconomic Indicators

CHAPTER 9 OTC Pharmaceuticals in Germany
9.1 Market Overview
Research Highlights
Market Analysis
9.2 Market Value
9.3 Market Segmentation I
9.4 Market Segmentation II
9.5 Market Share
9.6 Five Forces Analysis
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
9.7 Leading Companies
Bayer AG
Pfizer Inc
GlaxoSmithKline Plc
9.8 Distribution
9.9 Market Forecasts
Market Value Forecast
9.10 Macroeconomic Indicators

CHAPTER 10 OTC Pharmaceuticals in Italy
10.1 Market Overview
Research Highlights
Market Analysis
10.2 Market Value
10.3 Market Segmentation I
10.4 Market Segmentation II
10.5 Market Share
10.6 FIVE FORCES ANALYSIS
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
10.7 Leading Companies
Boehringer Ingelheim GmbH
Bayer AG
GlaxoSmithKline Plc
10.8 Distribution
10.9 Market Forecasts
Market Value Forecast
10.10 Macroeconomic Indicators

CHAPTER 11 OTC Pharmaceuticals in Japan
11.1 Market Overview
Research Highlights
Market Analysis
11.2 Market Value
11.3 Market Segmentation I
11.4 Market Segmentation II
11.5 Market Share
11.6 Five Forces Analysis
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
11.7 Leading Companies
Pfizer Inc
Novartis AG
Wyeth
11.8 Distribution
11.9 Market Forecasts
Market Value Forecast
11.10 Macroeconomic Indicators

CHAPTER 12 OTC Pharmaceuticals in the Netherlands
12.1 Market Overview
Research Highlights
Market Analysis
12.2 Market Value
12.3 Market Segmentation I
12.4 Market Segmentation II
12.5 Market Share
12.6 FIVE FORCES ANALYSIS
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
12.7 Leading Companies
Bayer AG
Pfizer Inc
Procter & Gamble Company, The
12.8 Distribution
12.9 Market Forecasts
Market Value Forecast
12.10 Macroeconomic Indicators

CHAPTER 13 OTC Pharmaceuticals in Spain
13.1 Market Overview
Research Highlights
Market Analysis
13.2 Market Value
13.3 Market Segmentation I
13.4 Market Segmentation II
13.5 Market Share
13.6 FIVE FORCES ANALYSIS
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
13.7 Leading Companies
Pfizer Inc
GlaxoSmithKline Plc
Sanofi-Aventis
13.8 Distribution
13.9 Market Forecasts
Market Value Forecast
13.10 Macroeconomic Indicators

CHAPTER 14 OTC Pharmaceuticals in the United Kingdom
14.1 Market Overview
Research Highlights
Market Analysis
14.2 Market Value
14.3 Market Segmentation I
14.4 Market Segmentation II
14.5 Market Share
14.6 Five Forces Analysis
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
14.7 Leading Companies
Pfizer Inc
GlaxoSmithKline Plc
Reckitt Benckiser PLC
Key Metrics
14.8 Distribution
14.9 Market Forecasts
Market Value Forecast
14.10 Macroeconomic Indicators

CHAPTER 15 OTC Pharmaceuticals in the United States
15.1 Market Overview
Research Highlights
Market Analysis
15.2 Market Value
15.3 Market Segmentation I
15.4 Market Segmentation II
15.5 Market Share
15.6 Five Forces Analysis
Summary
Buyer Power
Supplier Power
New Entrants
Substitutes
Rivalry
15.7 Leading Companies
Wyeth
Pfizer Inc
GlaxoSmithKline Plc
15.8 Distribution
15.9 Market Forecasts
Market Value Forecast
15.10 Macroeconomic Indicators

CHAPTER 16 Appendix
16.1 Methodology
16.2 Industry Associations
16.3 Related Datamonitor Research

LIST OF TABLES
Table 1: Global OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 2: Global OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 3: Global OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 4: Global OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 5: Key Facts: Pfizer Inc
Table 6: Key Financials: Pfizer Inc
Table 7: Key Facts: GlaxoSmithKline Plc
Table 8: Key Financials: GlaxoSmithKline Plc
Table 9: Key Facts: Novartis AG
Table 10: Key Financials: Novartis AG
Table 11: Global OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 12: Global OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 13: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 14: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 15: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 16: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 17: Key Facts: Nin Jiom
Table 18: Key Facts: Pfizer Inc
Table 19: Key Financials: Pfizer Inc
Table 20: Key Facts: Novartis AG
Table 21: Key Financials: Novartis AG
Table 22: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 23: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 24: Europe OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 25: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 26: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 27: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 28: Key Facts: Bayer AG
Table 29: Key Financials: Bayer AG
Table 30: Key Facts: Pfizer Inc
Table 31: Key Financials: Pfizer Inc
Table 32: Key Facts: GlaxoSmithKline Plc
Table 33: Key Financials: GlaxoSmithKline Plc
Table 34: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 35: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 36: Europe Exchange Rate, 2003
Table 37: Belgium OTC Pharmaceuticals Market Value: $ million, 2003-2007
Table 38: Belgium OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 39: Belgium OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 40: Belgium OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 41: Key Facts: Pfizer Inc
Table 42: Key Financials: Pfizer Inc
Table 43: Key Facts: Novartis AG
Table 44: Key Financials: Novartis AG
Table 45: Key Facts: Omega Pharma NV
Table 46: Key Financials: Omega Pharma NV
Table 47: Belgium OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 48: Belgium OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 49: Belgium Size of Population (million) , 2003-2007
Table 50: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 51: Belgium Inflation, 2003-2007
Table 52: Belgium Exchange Rate, 2003
Table 53: Canada OTC Pharmaceuticals Market Value: $ million, 2003-2007
Table 54: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 55: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 56: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 57: Key Facts: Pfizer Inc
Table 58: Key Financials: Pfizer Inc
Table 59: Key Facts: GlaxoSmithKline Plc
Table 60: Key Financials: GlaxoSmithKline Plc
Table 61: Key Facts: Jamieson Laboratories
Table 62: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 63: Canada OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 64: Canada Size of Population (million) , 2003-2007
Table 65: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 66: Canada Inflation, 2003-2007
Table 67: Canada Exchange Rate, 2003
Table 68: China OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 69: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 70: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 71: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 72: Key Facts: Johnson & Johnson
Table 73: Key Financials: Johnson & Johnson
Table 74: China OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 75: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 76: China Size of Population (million) , 2003-2007
Table 77: China GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 78: China Inflation, 2003-2007
Table 79: China Exchange Rate, 2003
Table 80: France OTC Pharmaceuticals Market Value: $ million, 2003-2007
Table 81: France OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 82: France OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 83: France OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 84: Key Facts: Procter & Gamble Company, The
Table 85: Key Financials: Procter & Gamble Company, The
Table 86: Key Facts: Sanofi-Aventis
Table 87: Key Financials: Sanofi-Aventis
Table 88: Key Facts: Pfizer Inc
Table 89: Key Financials: Pfizer Inc
Table 90: France OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 91: France OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 92: France Size of Population (million) , 2003-2007
Table 93: France GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 94: France Inflation, 2003-2007
Table 95: France Exchange Rate, 2003
Table 96: Germany OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 97: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 98: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 99: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 100: Key Facts: Bayer AG
Table 101: Key Financials: Bayer AG
Table 102: Key Facts: Pfizer Inc
Table 103: Key Financials: Pfizer Inc
Table 104: Key Facts: GlaxoSmithKline Plc
Table 105: Key Financials: GlaxoSmithKline Plc
Table 106: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 107: Germany OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 108: Germany Size of Population (million) , 2003-2007
Table 109: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 110: Germany Inflation, 2003-2007
Table 111: Germany Exchange Rate, 2003
Table 112: Italy OTC Pharmaceuticals Market Value: $ million, 2003-2007
Table 113: Italy OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 114: Italy OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 115: Italy OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 116: Key Facts: Boehringer Ingelheim GmbH
Table 117: Key Financials: Boehringer Ingelheim GmbH
Table 118: Key Facts: Bayer AG
Table 119: Key Financials: Bayer AG
Table 120: Key Facts: GlaxoSmithKline Plc
Table 121: Key Financials: GlaxoSmithKline Plc
Table 122: Italy OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 123: Italy OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 124: Italy Size of Population (million) , 2003-2007
Table 125: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 126: Italy Inflation, 2003-2007
Table 127: Italy Exchange Rate, 2003
Table 128: Japan OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 129: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 130: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 131: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 132: Key Facts: Pfizer Inc
Table 133: Key Financials: Pfizer Inc
Table 134: Key Facts: Novartis AG
Table 135: Key Financials: Novartis AG
Table 136: Key Facts: Wyeth
Table 137: Key Financials: Wyeth
Table 138: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 139: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 140: Japan Size of Population (million) , 2003-2007
Table 141: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 142: Japan Exchange Rate, 2003
Table 143: Netherlands OTC Pharmaceuticals Market Value: $ million, 2003-2007
Table 144: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 145: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 146: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 147: Key Facts: Bayer AG
Table 148: Key Financials: Bayer AG
Table 149: Key Facts: Pfizer Inc
Table 150: Key Financials: Pfizer Inc
Table 151: Key Facts: Procter & Gamble Company, The
Table 152: Key Financials: Procter & Gamble Company, The
Table 153: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 154: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 155: Netherlands Size of Population (million) , 2003-2007
Table 156: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 157: Netherlands Inflation, 2003-2007
Table 158: Netherlands Exchange Rate, 2003
Table 159: Spain OTC Pharmaceuticals Market Value: $ million, 2003-2007
Table 160: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 161: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 162: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 163: Key Facts: Pfizer Inc
Table 164: Key Financials: Pfizer Inc
Table 165: Key Facts: GlaxoSmithKline Plc
Table 166: Key Financials: GlaxoSmithKline Plc
Table 167: Key Facts: Sanofi-Aventis
Table 168: Key Financials: Sanofi-Aventis
Table 169: Spain OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 170: Spain OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 171: Spain Size of Population (million) , 2003-2007
Table 172: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 173: Spain Inflation, 2003-2007
Table 174: Spain Exchange Rate, 2003
Table 175: United Kingdom OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 176: United Kingdom OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 177: United Kingdom OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 178: United Kingdom OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 179: Key Facts: Pfizer Inc
Table 180: Key Financials: Pfizer Inc
Table 181: Key Facts: GlaxoSmithKline Plc
Table 182: Key Financials: GlaxoSmithKline Plc
Table 183: Key Facts: Reckitt Benckiser PLC
Table 184: Key Financials: Reckitt Benckiser PLC
Table 185: United Kingdom OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 186: United Kingdom OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 187: United Kingdom Size of Population (million) , 2003-2007
Table 188: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 189: United Kingdom Inflation, 2003-2007
Table 190: United Kingdom Exchange Rate, 2003
Table 191: United States OTC Pharmaceuticals Market Value: $ billion, 2003-2007
Table 192: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 193: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 194: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007
Table 195: Key Facts: Wyeth
Table 196: Key Financials: Wyeth
Table 197: Key Facts: Pfizer Inc
Table 198: Key Financials: Pfizer Inc
Table 199: Key Facts: GlaxoSmithKline Plc
Table 200: Key Financials: GlaxoSmithKline Plc
Table 201: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2007
Table 202: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012
Table 203: United States Size of Population (million) , 2003-2007
Table 204: United States GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 205: United States Inflation, 2003-2007